title: Transcatheter aortic valve implantation in patients with a mitral prosthesis; single center experience and review of literature.
abstract: OBJECTIVE
  Following the encouraging results of several registries and trials, transcatheter aortic valve implantation (TAVI) has been recognized as a valid option in patients with severe aortic stenosis deemed at high or prohibitive risk for surgical treatment. Good procedural success and good clinical outcomes have been showed and very limited data exist on TAVI in the setting of a preexisting mitral prosthesis regarding the technique, potential complications, and outcomes.
  
  
  METHODS
  Here, we report six cases of transfemoral TAVI with a self-expanding bioprosthesis (CoreValve; Medtronic, Inc) in patients who had previously undergone mitral valve replacement. Preprocedural, intraprocedural ve postprocedural outcome and data were analyzed and a brief literature review is also presented.
  
  
  CONCLUSIONS
  Our experiences show that transfemoral CoreValve implantation can be performed successfully in patients with mechanical and bioprosthetic mitral valves.
authors.affiliation: Hacettepe University Faculty of Medicine, Department of Cardiology, Ankara, Turkey.
authors.forename: Serkan
authors.initials: S
authors.lastname: Asil
authors.affiliation: Hacettepe University Faculty of Medicine, Department of Cardiology, Ankara, Turkey. Electronic address: mleventsahiner@yahoo.com.
authors.forename: Levent
authors.initials: L
authors.lastname: Şahiner
authors.affiliation: Hacettepe University Faculty of Medicine, Department of Cardiology, Ankara, Turkey.
authors.forename: Necla
authors.initials: N
authors.lastname: Özer
authors.affiliation: Hacettepe University Faculty of Medicine, Department of Cardiology, Ankara, Turkey.
authors.forename: E Barış
authors.initials: EB
authors.lastname: Kaya
authors.affiliation: Hacettepe University Faculty of Medicine, Department of Cardiology, Ankara, Turkey.
authors.forename: Banu
authors.initials: B
authors.lastname: Evranos
authors.affiliation: Hacettepe University Faculty of Medicine, Department of Cardiology, Ankara, Turkey.
authors.forename: Uğur
authors.initials: U
authors.lastname: Canpolat
authors.affiliation: Hacettepe University Faculty of Medicine, Department of Cardiology, Ankara, Turkey.
authors.forename: Hikmet
authors.initials: H
authors.lastname: Yorgun
authors.affiliation: Hacettepe University Faculty of Medicine, Department of Anesthesiology and Reanimation, Ankara, Turkey.
authors.forename: Heves
authors.initials: H
authors.lastname: Karagöz
authors.affiliation: Hacettepe University Faculty of Medicine, Department of Cardiology, Ankara, Turkey.
authors.forename: Kudret
authors.initials: K
authors.lastname: Aytemir
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001021:Aortic Valve / Q000000981:diagnostic imaging / Q000601:surgery; D001024:Aortic Valve Stenosis / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery; D006350:Heart Valve Prosthesis; D006801:Humans; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery*; D061330:Multidetector Computed Tomography / Q000379:methods; D011474:Prosthesis Design; D011475:Prosthesis Failure; D020379:Risk Adjustment / Q000379:methods; D012307:Risk Factors; D012720:Severity of Illness Index; D016896:Treatment Outcome
keywords: Aorta-mitral continuity; Mitral prosthesis; TAVİ